BordierP., RyckewartA., GubrisJ., RasmussenH.: On the pathogenesis of so-called idiopathic hypercalciuria. Amer. T. Med., 63; 398 (1977).
3.
BroadusA. E., DominguezM., BartterF. C.: Pathophysiological studies in idiopathic hypercalciuria: use of an oral tolerance test to characterize distinctive hypercalciuria subgroups. T. Clin Endocrinol Metab., 47; 751 (1978).
4.
BroadusA. E., MahaffeyJ. E., BartterF. C., NeerR. M.: Nephrogenous cyclic adenosine monophosphate as parathyroid function test. T. Clin. Invest., 60; 771 (1977).
5.
BroadusA. E., DeftosL. J., BartterF. C.: Effect of the intravenous administration of calcium on nephrogenous cyclic AMP: Use as a parathyroid function test. J. Clin. Endocrinol. Metab., 46; 447 (1978).
6.
CoeF. L., CanterburyJ. M., FirpoJ. J., ReissE.: Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria. J. Clin. Invest., 52; 134 (1973).
7.
CoeF. L.: Treatment of hypercalciuria. N. Engl. J. Med., 311; 116 (1984).
8.
Editorial: Pathogenesis of idiopathic hypercalciuria.Lancet, 2; 1001 (1984).
9.
GilmanA. G.: A protein binding assay for adenosine 3’ – 5’ cyclic monophosphate. Proc. Nat. Acad. Sci., 67; 305 (1970).
KaminskyN. I., BroadusA. E., HardmanJ. G., JonesD. J.Jr., BallJ. H., SutherlandE. W., LiddleG. W.: Effects of parathyroid hormone on plasma and urinary adenosine 3'–5’ monophosphate in man. J. Clin. Invest., 49; 2387 (1970).
12.
LiddleG. W., HardmanJ. G.: Cyclic adenosine monophosphate as a mediator of hormone action. N. Engl. J. Med., 285; 560 (1971).
13.
MuldowneyF. P., FreaneyR., BoneH., McMullinJ. P., TowersR. P., SpillaneA., O'ConnorP., DonohueP., MaloneyM.: Serum ionized calcium and parathyroid hormone in renal stone disease. Quart. J. Med., 45; 75 (1976).
14.
MuradF., PakC. Y. C.: Urinary excretion of adenosine 3'–5’ monophosphate and guanosine 3'–5’ monophosphate. N. Engl. J. Med., 286; 1373 (1972).
15.
NordinB. E. C., PeacockM., WilkinsonR.: Hypercalciuria and calcium stone disease. J. Clin. Endocrinol. Metab., 269; 183 (1972).
16.
PakC. Y. C., EastD. A., SanzenbacherL. J., DeleaC. S., BartterF. C.: Gastrointestinal calcium absorption in nephrolitiasis. J. Clin. Endocrinol. Metab., 35; 261 (1972).
17.
PakC. Y. C., OataM., LawrenceE. C., SynderW.: The hypercalciurias. Causes, parathyroid function and diagnostic criteria. J. Clin. Invest., 54; 387 (1974).
18.
PakC. Y. C., KaplanR., BoneH., TownsendJ., WatersO.: A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias. N. Engl. J. Med., 292; 497 (1975).
19.
PakC. Y. C., BrittonF., PetersonR., WardD., NorthcuttC., BreslauN. A., McGuireJ., SakhaeeK., BushS., NicarM., NormanD., PetersP.: Ambulatory evaluation of nephrolitiasis. Classification, clinical presentation and diagnostic criteria. Amer. J. Med., 69; 19 (1980).
20.
RobinsonG. A., ButcherE., SutherlandE. W.: Cyclic AMP. New York Academic Press, 1971.
21.
RushW. H., BoyceW. H., ResnickM. I.: Cyclic adenosine monophosphate: relationship to calcium metabolism and renal lithiasis. J. Urol., 117; 150 (1977).
22.
SteeinerA. L., KipnisD. M., UtigerR., ParkerC.: Radioimmunoassay for the measurement of adenosine 3’ – 5’ cyclic phosphate. Proc. Nat. Acad. Sci., 64; 367 (1969).
23.
Schmidt-GaykH., RoherH. D.: Urinary excretion of cyclic adenosine monophosphate in the detection and diagnosis of primary hyperparathyroidism. Surg., Gynec. & Obstet., 137; 439 (1973).
24.
SegreG. V., HabenerJ. F., PowellD., TegrearG. W., PottsJ. T.Jr.: Parathyroid hormone in human plasma: immunochemical characterization and biological implication. T. Clin. Invest., 51; 3163 (1972).
25.
YendtE. R.: Renal calculi. Canad. Med. Ass. J., 102; 479 (1970).